Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 20.61B | 21.15B | 19.58B | 19.54B | 18.83B | 18.33B |
Gross Profit | 15.42B | 15.79B | 14.76B | 14.84B | 14.34B | 14.11B |
EBITDA | 849.12M | 1.27B | 1.02B | 1.25B | 918.79M | 990.51M |
Net Income | 198.55M | 254.16M | 225.27M | 514.14M | 423.42M | 121.81M |
Balance Sheet | ||||||
Total Assets | 19.61B | 20.20B | 22.02B | 18.05B | 17.34B | 18.01B |
Cash, Cash Equivalents and Short-Term Investments | 1.17B | 2.12B | 2.56B | 2.56B | 5.29B | 7.28B |
Total Debt | 1.82B | 1.54B | 3.67B | 175.36M | 125.93M | 732.95M |
Total Liabilities | 5.43B | 5.57B | 7.46B | 3.80B | 3.55B | 4.65B |
Stockholders Equity | 14.18B | 14.63B | 14.56B | 14.25B | 13.80B | 13.36B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.43B | -1.15B | -802.37M | -298.09M | 2.41B |
Operating Cash Flow | 0.00 | 1.71B | -849.03M | -264.54M | 101.72M | 2.94B |
Investing Cash Flow | 0.00 | 442.01M | -2.41B | -2.23B | -1.29B | -1.00B |
Financing Cash Flow | 0.00 | -2.60B | 3.27B | -239.05M | -782.97M | 424.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥6.74B | 7.99 | 3.06% | -9.85% | -8.43% | ||
79 Outperform | ¥8.98B | 6.17 | 2.45% | 1.86% | -13.39% | ||
76 Outperform | ¥8.05B | 53.61 | 3.06% | -3.35% | -41.42% | ||
70 Outperform | ¥9.02B | 35.44 | 1.12% | 8.01% | 13.50% | ||
68 Neutral | ¥8.93B | 21.75 | 7.41% | -6.22% | -84.85% | ||
62 Neutral | C$5.19B | 9.07 | 20.23% | 3.58% | 3.46% | 8.83% | |
47 Neutral | ¥6.00B | ― | 2.11% | -12.30% | -274.85% |